24 . October , 2018 - Wednesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Eletriptan Hydrobromide

Big Image Pronouncation: (ell-eh-TRIP-tan HIGH-droe-BROE-mide)
Class: Serotonin 5-HT 1 receptor agonist

Trade Names:
- Tablets 24.2 mg
- Tablets 48.5 mg

Mechanism of Action


Selective agonist for vascular serotonin (5-HT 1 ) receptor subtype, causing vasoconstriction of cranial arteries.



Eletriptan is well absorbed, reaching a peak plasma level in approximately 1.5 h. The mean absolute bioavailability is approximately 50%.


Eletriptan is approximately 85% protein bound. The Vd is 138 L after IV injection.


The N-demethylated metabolite is active.


The terminal elimination t ½ is approximately 4 h. The mean renal Cl is 3.9 L/h after oral administration. Non-renal Cl accounts for about 90% of total Cl.

Special Populations

Hepatic Function Impairment

Mild to moderate impairment results in an increase in both AUC (34%) and t ½ , while the peak plasma level increased 18%.


Increased t ½ from about 4.4 to 5.7 h in elderly (65 to 93 yr of age).


Increased t ½ from about 4.4 to 5.7 h in younger subjects (18 to 45 yr of age).

Indications and Usage

Acute treatment of migraine with or without aura.


Ischemic heart disease (eg, angina pectoris); symptoms or findings consistent with ischemic heart disease; coronary artery vasospasm (including Prinzmetal variant angina); significant underlying CV disease; cerebrovascular syndromes (including strokes of any type or transient ischemic attacks); peripheral vascular disease (including ischemic bowel disease); uncontrolled hypertension; hemiplegic or basilar migraine; severe hepatic function impairment; hypersensitivity to any component of the product; within 24 h of treatment with another 5-HT 1 agonist or an ergotamine-containing or ergot-type medication (eg, methysergide).

Dosage and Administration


PO 20 to 40 mg single dose. If required, a second dose may be taken at least 2 h after the initial dose (max, 80 mg/day).

If headache recurs after initial relief, a second tablet may be administered, provided there is an interval of at least 2 h between doses. If first dose is ineffective, do not administer a second dose unless prescribed by health care provider.


Store at controlled room temperature (59° to 86°F).

Drug Interactions

Ergot derivatives (eg, dihydroergotamine)

Risk of vasospastic reactions may be increased. Concomitant use within 24 h of eletriptan is not recommended.

Other 5-HT 1 agonists

Concomitant use of other 5-HT 1 agonists within 24 h of eletriptan is not recommended.

Potent CYP-450 3A4 inhibitors (eg, clarithromycin, itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, troleandomycin)

Eletriptan should not be used within 72 h of drugs that are potent CYP3A4 inhibitors.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Palpitation (at least 1%); coronary artery vasospasm; transient myocardial ischemia; MI; ventricular tachycardia; ventricular fibrillation.


Dizziness, somnolence (7%); headache (4%); hypertonia, hypesthesia, paresthesia, vertigo (at least 1%).


Sweating (at least 1%).


Nausea (8%); dry mouth (4%); dyspepsia, dysphagia (eg, throat tightness, difficulty swallowing) (2%).


Pharyngitis (at least 1%).


Asthenia (10%); pain, tightness, or pressure of chest (4%); stomach pain, cramps, or pressure, abdominal pain or discomfort (2%); back pain, chills (at least 1%).



Symptoms of migraine attack

Assess pain location, intensity, duration, and associated symptoms of migraine attack and response to treatment.


Category C .


Excreted in breast milk.


Safety and efficacy not established.


There is an increased t ½ (from about 4.4 to 5.7 h) in the elderly (65 to 93 yr of age).

CV/Cardiac events

It is recommended that eletriptan not be given to patients in whom unrecognized coronary artery disease (CAD) is predicted based on the presence of risk factors (eg, hypertension, hypercholesterolemia, smoker, obesity, diabetes, strong family history of CAD, women with surgical or physiological menopause, men older than 40 yr of age). Serious adverse cardiac events, including MI, life-threatening disturbances of cardiac rhythm, and death have been reported within a few hours of administration of a 5-HT 1 agonist.

Cerebrovascular events

Cerebral hemorrhage, subarachnoid hemorrhage, stroke, and other cerebrovascular events have been reported with 5-HT 1 agonists.

Hypertensive crisis

Elevation in BP, including hypertensive crisis, have been reported with administration of 5-HT 1 agonists.



Hypertension or other more serious CV symptoms may occur.

Patient Information

  • Advise patient to read the patient information leaflet before starting therapy and again with each refill.
  • Explain that drug is to be used only during migraine and does not prevent or reduce the number of attacks. Emphasize that drug is used only to treat actual migraine attack and should not be used to prevent migraine headaches or treat headaches caused by other conditions.
  • Advise patient that drug is to be taken as soon as symptoms of migraine appear. A second dose may be taken if symptoms return, but no sooner than 2 h following the first dose. For a given attack, if there is no response to the first tablet, do not take a second tablet without first consulting with health care provider. Do not take more than 2 tablets in any 24-h period.
  • Advise patient that safety of treating more than 3 headaches in a 30-day period has not been established and to inform health care provider if headaches are occurring more frequently.
  • Advise patient to immediately notify health care provider if any of the following occur after taking a dose of frovatriptan: severe chest pain or chest pain that does not go away; sudden and/or severe stomach pain; shortness of breath; wheezing; swelling of eyelids, face, or lips.
  • Advise patient that if tightness, pain, pressure or heaviness in chest, throat, neck, or jaw occurs when using sumatriptan, to discuss these symptoms with health care provider before using again.
  • Advise patient to notify health care provider if feelings of tingling, heat, flushing, tiredness, dizziness, heaviness, or pressure after treatment occur.
  • Advise patient that drug may cause fatigue or dizziness and to use caution while driving or performing other activities requiring mental alertness.
  • Advise patient to avoid unnecessary exposure to sunlight or tanning lamps and to use sunscreen and wear protective clothing to avoid photosensitivity reactions.
  • Instruct patient to continue to take migraine prophylactic medications daily as directed.
  • Advise patient not currently taking a migraine prophylactic drug to discuss the use of such drugs with health care provider.

Recent Drug Updates at DrugIndexOnline:

cetirizine and pseudoephedrine cetirizine and pseudoephedrine
Generic Name: cetirizine and pseudoephedrine (seh TEER ih zeen and soo doe eh FEH drin) Brand Names: Zyrtec-D What is cetirizine and pseudoephedrine? Cetirizine is an antihistamine. Cetirizine blocks the actions of the naturally occurring chemical histamine in the body. Cetirizine is les more...

Cortisporin otic suspension Cortisporin otic suspension
Generic Name: (neomycin sulfate, polymyxin B sulfate and hydrocortisone Dosage Form: Otic suspension Description Cortisporin® Otic Suspension (neomycin and polymyxin B sulfates and hydrocortisone otic suspension, USP) is a sterile antibacterial and anti-inflammatory suspension for otic use. E more...

Glycine Glycine
Dosage Form: Irrigation usp NONELECTROLYTE IRRIGATING FLUID FOR TRANSURETHRAL SURGICAL PROCEDURES. For Urologic Irrigation Only; Not For Injection By Usual Parenteral Routes Flexible Irrigation Container Rx only Glycine Description 1.5% Glycine Irrigation, USP is a sterile, nonpyrogenic, hypot more...

Hydrochlorothiazide/Telmisartan Hydrochlorothiazide/Telmisartan
Generic Name: Hydrochlorothiazide/Telmisartan (HYE-droe-KLOR-oh-THYE-a-zide/TEL-mi-SAR-tan) Brand Name: Micardis HCTHydrochlorothiazide/Telmisartan can cause injury or even death to a developing fetus when used after the third month of pregnancy. Contact your doctor immediately if you suspect t more...

Meprobamate Meprobamate
Dosage Form: Tablets Meprobamate Description Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether. The structural formula of Meprobamate is: C9H18N2O4   & more...

Midamor Midamor
Generic Name: amiloride (a MIL o ride) Brand Names: Midamor What is Midamor (amiloride)? Amiloride is a potassium-sparing diuretic (water pill) that prevents your body from absorbing too much salt and keeps your potassium levels from getting too low. Amiloride is used to treat or preven more...

Neo-Dex Neo-Dex
Generic Name: neomycin and dexamethasone ophthalmic (nee oh MY sin/dex ah METH ah sone) Brand Names: AK-Neo-Dex, Neo-Decadron, Neo-Decadron Ocumeter, Neo-Dex, Neo-Dexair What is Neo-Dex (neomycin and dexamethasone ophthalmic)? Neomycin is an antibiotic. It is used to treat bacterial inf more...

Novo-Folacid Novo-Folacid
Some commonly used brand names are: In the U.S.— Folvite In Canada— Apo-Folic Folvite Novo-Folacid Generic name product may be available in the U.S. and Canada. Another commonly used name is Vitamin B 9 . Category Diagnostic aid, folate deficiency Nutritional supplement, vita more...